A clinical trial examining the efficacy of two devices to monitor and detect atrial fibrillation (AF), or an irregular heartbeat, in ischemic stroke patients -- one an implantable device that monitors over 12 months, the other an external device that monitors over a 30-day period -- found the implantable device is more than three times more effective in detecting AF.
from Top Health News -- ScienceDaily https://ift.tt/34D0bcj
Subscribe to:
Post Comments (Atom)
Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO
However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...
-
India is the largest market by users for both Facebook and its messenger service WhatsApp from Home Page https://ift.tt/3aUtevW via IFTTT...
-
The Finance Industry Development Council (FIDC) has urged the Ministry of Micro, Small & Medium Enterprises (MSME) to address issues fac...
-
Prime Minister Narendra Modi on Saturday said that both India and Bangladesh want to see peace, stability, and love instead of instability, ...
No comments:
Post a Comment